When it comes to overseas agency rights, Anna is indeed very sincere and has offered the best cooperation agreement.

……

……

"The factory price is 5000 per box. There's nothing wrong with that."

"If you add in the agent's profit and local taxes, the monthly cost of medicine is about 25000 yuan, which is in line with international market conditions."

"I estimate that this pricing will not cause any objections from other pharmaceutical companies, and therefore they will not target our group."

Luo Shiyun said again.

Naturally, she had no objection to the factory price of 5000 yuan per box.

The profit generated by this pricing is high enough to give other pharmaceutical giants a sigh of relief.

As long as it complies with international market conditions and the selling price is lower only in the Chinese market, these pharmaceutical giants will not target Antai Pharmaceutical Group.

As for whether domestic pharmaceutical companies will make trouble, that is not a problem that Antai Pharmaceutical Group needs to consider.

If these pharmaceutical companies dare to express dissatisfaction, someone will naturally deal with them, and there is no need for Anta Group to take action.

After all, this is the result of the efforts of the Chinese government. If any of these pharmaceutical companies dare to express dissatisfaction with this, they will naturally face the wrath of the higher authorities.

"It doesn't matter whether these pharmaceutical companies target us or not."

"My goal is just to make money, not to satisfy these pharmaceutical companies. What they think is none of my business."

"This wave of pricing is 5000 yuan per box. We will first make all the money from these wealthy people, and then force other countries to lower tariffs, and then we will further reduce the price."

Chen Xuan made this decision coldly.

He never cared about the threats from these international pharmaceutical giants.

In fact, if he can make more money by lowering the price, he will do so without hesitation.

Even if doing so would make him the public enemy of these giants, it would not stop him from doing so.

It's just that now he has to set a high price so that he can make a lot of money and avoid making such a mess. But this is not considering the feelings of these pharmaceutical giants, but purely from the perspective of maximizing profits.

Chen Xuan had also thought it through. He would first make money from foreign tycoons, then lower the price of drugs to make money from the middle class, and then the money from the lower class.

Make money layer by layer.

Anyway, his medicine can cure diseases, keep patients alive, and ensure their quality of life, so he deserves some appropriate compensation.

He also asked himself if he had a clear conscience. Compared with other pharmaceutical companies, his company was very conscientious and only made the money it deserved.

The drugs from other pharmaceutical companies may not be effective, and they are also very expensive. In comparison, his is indeed more conscientious, at least the efficacy of the drugs is completely fine.

"By the way, Pfizer has set its sights on a pharmaceutical company."

"This is also a newly established pharmaceutical company, but it has an anti-cancer drug that has already entered Phase III clinical trials."

"Based on current information, the success rate is relatively high, and Pfizer is likely to acquire an entire pharmaceutical company just for this drug."

Luo Shiyun suddenly mentioned this matter.

It is very common for these international pharmaceutical companies to acquire other pharmaceutical companies. Acquisitions, mergers and cooperation are all very common practices.

Under normal circumstances, she wouldn't need to tell Chen Xuan about this matter specifically, but since this matter involves Pfizer, it is naturally completely different.

After all, she also knew that Chen Xuan was shorting Pfizer and had leveraged 1000 billion in funds, which was arguably the largest short position at the moment. Any news about Pfizer was very important.

"Acquiring a pharmaceutical company?"

Chen Xuan was indeed a little surprised.

But this kind of acquisition is also normal.

Some small companies are lucky enough to develop new drugs that are very promising.

At this time, these international giants will directly acquire these small companies, and the acquisition price is not low.

Tap the screen to use advanced tools Tip: You can use left and right keyboard keys to browse between chapters.

You'll Also Like